CARLA CHRISTO: Open Payments
NPI 1730810466 · ORANGE CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,694 in 51 payments from 26 companies in 2025. Trend: 2023 $1,997 · 2024 $3,493 · 2025 $1,694
Food & beverage: $944Long term medical supply or device loan: $750
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $839 |
| BeOne Medicines USA, Inc. | 3 | $68 |
| Janssen Biotech, Inc. | 3 | $66 |
| AstraZeneca Pharmaceuticals LP | 2 | $62 |
| TerSera Therapeutics LLC | 2 | $53 |
| EMD Serono, Inc. | 2 | $48 |
| Daiichi Sankyo Inc. | 2 | $46 |
| Geron Corporation | 3 | $46 |
| Caris MPI, Inc. | 2 | $45 |
| SOBI, INC | 1 | $44 |
Products named: KISQALI, IMFINZI, BRUKINSA, Zoladex, TEVIMBRA, Enhertu, RYTELO, MI CANCER SEEK.
Industry payments across FL — which companies pay providers there.
